DATA SHEET 1 CLEXANE AND CLEXANE FORTE 2 ... …

ADVANTAN Presentation Uses - Medsafe

ADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.

  Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate

LOXALATE 1. Product Name - Medsafe Home Page

Page 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.

  Risks, Combination

SEPTANEST Articaine hydrochloride 4% with …

SEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.

  Articaine

BOOSTRIX - Medsafe Home Page

1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.

  Information, Boostrix

NEW ZEALAND DATA SHEET - Medsafe

NEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a

  Cymevene

Edition Draft - Medsafe

Part 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for

  Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice

Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …

New Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …

  Product, Name, Sheet, Data, Data sheet 1 product name

NEW ZEALAND DATA SHEET MESTINON® - Medsafe

NEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to

  Myasthenia, Gravis, Myasthenia gravis, Mestinon

DATA SHEET PREDNISONE - Medsafe

• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since

  Myasthenia, Gravis, Myasthenia gravis, Prednisone

NEW ZEALAND DATA SHEET - Medsafe

Redipred – Data Sheet Page 3 of 11 dosage appear to be important factors in determining suppression of the pituitary adrenal axis and response to stress on cessation of steroid treatment.

  Stress, Redipred

HIGHLIGHTS OF PRESCRIBING INFORMATION ...

3 full prescribing information warning: embryo-fetal toxicity, hematologic toxicity, and venous and arterial thromboembolism embryo-fetal toxicity

  Venous, Thromboembolism

Venous Thromboembolism Prophylaxis: The role …

AUSTRALIAN JOURNAL OF ADVANCED NURSING Volume 27 Number 3 84 SCHOLARLY PAPER INTRODUCTION VTE is the term that describes two clinical conditions: deep vein thrombosis (DVT) and pulmonary embolism

  Roles, The role, Venous, Thromboembolism, Prophylaxis, Venous thromboembolism prophylaxis

A Practical Guide to Prescribing Hormone …

A Practical Guide to Prescribing Hormone Replacement Therapy Karen A. McKinney and William Thompson Department of Obstetrics and Gynaecology, Queen’s University of Belfast, Belfast, Northern Ireland

  Guide, Practical, Replacement, Therapy, Prescribing, Practical guide to prescribing hormone, Hormone, Practical guide to prescribing hormone replacement therapy

Guidelines For Antithrombotic Therapy - Welcome …

1 Guidelines For Antithrombotic Therapy Last updated December 2003 I. Initiation of Anticoagulant Therapy II. Warfarin Anticoagulation III. …

  Guidelines, Therapy, Guidelines for antithrombotic therapy, Antithrombotic

NEW ORAL ANTICOAGULANTS FOR VENOUS …

NEW ORAL ANTICOAGULANTS FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN THE FOOT AND ANKLE Matthew Q. McCammon, DPM INTRODUCTION Venous thromboembolism (VTE) is a common cause of

  Oral, Anticoagulant, Venous, Thromboembolism, Prophylaxis, Venous thromboembolism, Oral anticoagulants for venous, Oral anticoagulants for venous thromboembolism prophylaxis

Venous Thromboembolism Prophylaxis Guidelines

VANDERBILT UNIVERSITY MEDICAL CENTER MULTIDISCIPLINARY SURGICAL CRITICAL CARE Venous Thromboembolism Prophylaxis Guidelines Purpose: To provide guidance on preventing venous thromboembolism (VTE) in the surgical intensive care unit (SICU) at Vanderbilt University Medical Center (VUMC).

  Guidelines, Venous, Venous thromboembolism prophylaxis guidelines, Thromboembolism, Prophylaxis, Venous thromboembolism

When patients on warfarin need surgery - Zunis

CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 70 • NUMBER 11 NOVEMBER 2003973 HE MORE THAN 2 million patients in North America who take warfarin1 face a major problem should they need surgery or

  Patients, Surgery, Major, Needs, Warfarin, Patients on warfarin need surgery

HIGHLIGHTS OF PRESCRIBING INFORMATION

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use XULANE® safely and effectively. See full prescribing information for XULANE.